Clinical Trials Browser

Phase NA × INDUSTRY × Urinary Bladder Neoplasms × Clear all

Congenital Abnormalities, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Cystitis, Interstitial

NCT07231809 2025-11-21

HIVEC

Phase NA Not yet recruiting

50 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma

NCT06394869 2025-11-10

CREDIBLE

Phase NA Recruiting

1,000 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06940648 2025-05-06

VIABLE

Phase NA Enrolling by invitation

30 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06136312 2025-04-09

Clinical Investigation of the Multi4 System

Phase NA Completed

18 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06422312 2025-04-04

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Phase NA Withdrawn

Genitourinary

Urinary Bladder Calculi, Urinary Bladder Neck Obstruction, Urinary Bladder Neoplasms, Kidney Diseases, Nephrolithiasis

NCT06780358 2025-01-17

RAISE02

Phase NA Enrolling by invitation

64 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05184725 2022-08-01

CARINAE

Phase NA Completed

50 enrolled

Genitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Scoliosis, Stress, Psychological

NCT04190641 2021-10-14

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

Phase NA Completed

4 enrolled

Genitourinary

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT02647112 2021-05-04

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

Phase NA Completed

1,050 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02700464 2021-05-04

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Phase NA Completed

680 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT01803295 2017-06-16

OPTIMA

Phase NA Completed

80 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT02891460 2016-09-08

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Phase NA Completed

18 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01799499 2015-09-01

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT02496442 2015-07-14

Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan

Phase NA Unknown

30 enrolled

Genitourinary

Urinary Bladder Neoplasms, Kidney Calculi, Prostatic Hyperplasia

NCT01648010 2013-05-07

Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer

Phase NA Completed

7 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Clinical Trials

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

HIVEC

CREDIBLE

VIABLE

Clinical Investigation of the Multi4 System

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

RAISE02

CARINAE

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

OPTIMA

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

NMIBC TURBT HG

Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan

Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer